Sort   by:  
 Page size 
GenomicsAngiogenesis study of Gd@C82(OH)22 nanoparticle
Angiogenesis study of Gd@C82(OH)22 nanoparticle
PRJNA99999 | ENA
TranscriptomicsAngiogenesis study of Gd@C82(OH)22 nanoparticle
we report a novel nanomedicine (Gd@C82(OH)22 ) effectively inhibit human breast tumor growth by antiangiogenesis in vivo. To further identify which angiogenic factor(s) were affected on mRNA level, the "RT² Profiler™ PCR Array Mouse Angiogenesis (APMM-024, SuperArray Bioscience Corporation)" was use...
ORGANISM(S): Homo sapiens Mus musculus 
2009-04-01 | GSE7861 | GEO
ProteomicsAnalyses of the essential C82 subunit uncover some differences in RNA polymerase III transcription between Trypanosoma brucei and Leishmania major
The 17-subunit RNA polymerase III (RNAP III) synthesizes essential untranslated RNAs such as tRNAs and 5S rRNA. In yeast and vertebrates, subunit C82 forms a stable subcomplex with C34 and C31 that is necessary for promoter-specific transcription initiation. Little is known about RNAP III transcript...
ORGANISM(S): Trypanosoma brucei Leishmania major strain Friedlin 
2024-11-13 | PXD051017 | Pride
C82  leishmania major  trypanosoma brucei  rnap iii transcription  trna  orbitrap lumos 
TranscriptomicsAngiogenesis study of Gd@C82(OH)22 nanoparticle
we report a novel nanomedicine (Gd@C82(OH)22 ) effectively inhibit human breast tumor growth by antiangiogenesis in vivo. To further identify which angiogenic factor(s) were affected on mRNA level, the "RT² Profiler™ PCR Array Mouse Angiogenesis (APMM-024, SuperArray Bioscience Corporation)&qu...
ORGANISM(S): Mus musculus 
2009-04-01 | E-GEOD-7861 | biostudies-arrayexpress
TranscriptomicsExpression data from skin biopsies in patients with systemic sclerosis treated with beta-catenin inhibitor (C82) and placebo
Wnt signaling pathway is thought to have a role in skin fibrosis in Systemic slcerosis. This Randomized, Placebo-Controlled trial examines the effect of beta catenin inhibition on skin expression. We used microarrays to explore gene expression changes in the C82 trial
ORGANISM(S): Homo sapiens 
2018-01-01 | GSE94340 | GEO
UnknownEffects of Aqueous Dispersions of C60, C70 and Gd@C82 Fullerenes on Genes Involved in Oxidative Stress and Anti-Inflammatory Pathways.
Not available
S-EPMC8201376 | biostudies-literature
UnknownAnalyses of the essential C82 subunit uncovered some differences in RNA polymerase III transcription between <i>Trypanosoma brucei</i> and <i>Leishmania major</i>.
Not available
S-EPMC11894013 | biostudies-literature
UnknownAngiogenesis study of Gd@C82(OH)22 nanoparticle
Not available
ORGANISM(S): Homo sapiens 
S-ECPF-GEOD-7861 | biostudies-other
GenomicsHomo sapiens
Expression data from skin biopsies in patients with systemic sclerosis treated with beta-catenin inhibitor (C82) and placebo
PRJNA369403 | ENA
UnknownS2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
Not available
S-EPMC9325452 | biostudies-literature
Sort   by:  
 Page size